OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Press Releases and News

divider

ROCKVILLE, MD -- Feb 26, 2014 – OriGene Technologies, Inc. (“OriGene”), one of the industry leaders in producing genome wide products for research and diagnostic applications, announced today that it has acquired BioCheck, Inc., a provider of innovative immunodiagnostic test kits and custom immunoassay development for the world-wide health care and research markets.. (Full Press Release)
ROCKVILLE, MD--(Jan 30, 2014) – OriGene Technologies, Inc. (“OriGene”), one of the industry leaders in producing genome wide products for research and diagnostic applications, has been awarded a contract from the National Cancer Institute (NCI) to develop high affinity anti-peptide antibodies for SISCAPA assays.. (Full Press Release)
Rockville, MD. May 30th, 2013 - Scientists from Peking University, China and OriGene Technologies jointly published that multiple lineage specifier genes can replace OCT4 and SOX2 during reprogramming, the core regulators of cell pluripotency.. (Full Press Release)

More press release & news...


Conferences

Where OriGene scientists are presenting their findings and new product launches
divider

AAI 2014
May 02-May 06, 2014, Pittsburgh, PA. Booth #406

PEGS Summit 2014
May 04-May 09, 2014, Boston, MA. Booth #325

Neuroscience 2014
Nov 15-Nov 19, 2014, Washington, D.C.. Booth #1119

 

spacer
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title